Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

No evidence for clinical utility in investigating the connexin genes GJB2, GJB6 and GJA1 in non-syndromic hearing loss in black Africans.

Wonkam A, Bosch J, Noubiap JJ, Lebeko K, Makubalo N, Dandara C.

S Afr Med J. 2015 Jan;105(1):23-6.

PMID:
26046157
2.

Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.

Duchatelet S, Hovnanian A.

J Invest Dermatol. 2015 Jun;135(6):1475-8. doi: 10.1038/jid.2014.535.

PMID:
25964267
3.

Connexin-43 downregulation in G2/M phase enriched tumour cells causes extensive low-dose hyper-radiosensitivity (HRS) associated with mitochondrial apoptotic events.

Ghosh S, Kumar A, Chandna S.

Cancer Lett. 2015 Jul 10;363(1):46-59. doi: 10.1016/j.canlet.2015.03.046. Epub 2015 Apr 2.

PMID:
25843295
4.

Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43.

García IE, Maripillán J, Jara O, Ceriani R, Palacios-Muñoz A, Ramachandran J, Olivero P, Perez-Acle T, González C, Sáez JC, Contreras JE, Martínez AD.

J Invest Dermatol. 2015 May;135(5):1338-47. doi: 10.1038/jid.2015.20. Epub 2015 Jan 27.

PMID:
25625422
5.

Impact of obesity on 7,12-dimethylbenz[a]anthracene-induced altered ovarian connexin gap junction proteins in female mice.

Ganesan S, Nteeba J, Keating AF.

Toxicol Appl Pharmacol. 2015 Jan 1;282(1):1-8. doi: 10.1016/j.taap.2014.10.020. Epub 2014 Nov 8.

PMID:
25447408
6.

Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.

Boyden LM, Craiglow BG, Zhou J, Hu R, Loring EC, Morel KD, Lauren CT, Lifton RP, Bilguvar K; Yale Center for Mendelian Genomics, Paller AS, Choate KA.

J Invest Dermatol. 2015 Jun;135(6):1540-7. doi: 10.1038/jid.2014.485. Epub 2014 Nov 14.

PMID:
25398053
7.
8.

Prostaglandin F2α regulates the expression of uterine activation proteins via multiple signalling pathways.

Xu C, You X, Liu W, Sun Q, Ding X, Huang Y, Ni X.

Reproduction. 2015 Jan;149(1):139-46. doi: 10.1530/REP-14-0479. Epub 2014 Oct 23.

PMID:
25342173
9.

Expression of Cx43 and Pax3 proteins in the human placental villi and decidua during early pregnancy.

Zhang J, Zhang L, Liu X, Zhou F.

Biomed Mater Eng. 2014;24(6):3841-7. doi: 10.3233/BME-141214.

PMID:
25227101
10.

Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions.

Patel DM, Dubash AD, Kreitzer G, Green KJ.

J Cell Biol. 2014 Sep 15;206(6):779-97. doi: 10.1083/jcb.201312110.

11.

Screening of diagnostic markers for osteosarcoma.

Wu D, Chen K, Bai Y, Zhu X, Chen Z, Wang C, Zhao Y, Li M.

Mol Med Rep. 2014 Nov;10(5):2415-20. doi: 10.3892/mmr.2014.2546. Epub 2014 Sep 8.

PMID:
25199469
12.

Exome sequencing reveals mutation in GJA1 as a cause of keratoderma-hypotrichosis-leukonychia totalis syndrome.

Wang H, Cao X, Lin Z, Lee M, Jia X, Ren Y, Dai L, Guan L, Zhang J, Lin X, Zhang J, Chen Q, Feng C, Zhou EY, Yin J, Xu G, Yang Y.

Hum Mol Genet. 2015 Jan 1;24(1):243-50. doi: 10.1093/hmg/ddu442. Epub 2014 Aug 28.

PMID:
25168385
13.

Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.

Sinner MF, Tucker NR, Lunetta KL, Ozaki K, Smith JG, Trompet S, Bis JC, Lin H, Chung MK, Nielsen JB, Lubitz SA, Krijthe BP, Magnani JW, Ye J, Gollob MH, Tsunoda T, Müller-Nurasyid M, Lichtner P, Peters A, Dolmatova E, Kubo M, Smith JD, Psaty BM, Smith NL, Jukema JW, Chasman DI, Albert CM, Ebana Y, Furukawa T, Macfarlane PW, Harris TB, Darbar D, Dörr M, Holst AG, Svendsen JH, Hofman A, Uitterlinden AG, Gudnason V, Isobe M, Malik R, Dichgans M, Rosand J, Van Wagoner DR; METASTROKE Consortium; AFGen Consortium, Benjamin EJ, Milan DJ, Melander O, Heckbert SR, Ford I, Liu Y, Barnard J, Olesen MS, Stricker BH, Tanaka T, Kääb S, Ellinor PT.

Circulation. 2014 Oct 7;130(15):1225-35. doi: 10.1161/CIRCULATIONAHA.114.009892. Epub 2014 Aug 14.

PMID:
25124494
14.

AMSH-mediated deubiquitination of Cx43 regulates internalization and degradation of gap junctions.

Ribeiro-Rodrigues TM, Catarino S, Marques C, Ferreira JV, Martins-Marques T, Pereira P, Girão H.

FASEB J. 2014 Nov;28(11):4629-41. doi: 10.1096/fj.13-248963. Epub 2014 Jul 28.

PMID:
25070368
15.

Internal translation of the connexin 43 transcript.

Salat-Canela C, Sesé M, Peula C, Ramón y Cajal S, Aasen T.

Cell Commun Signal. 2014 May 8;12:31. doi: 10.1186/1478-811X-12-31.

16.

Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice.

Abed A, Toubas J, Kavvadas P, Authier F, Cathelin D, Alfieri C, Boffa JJ, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

Kidney Int. 2014 Oct;86(4):768-79. doi: 10.1038/ki.2014.108. Epub 2014 May 21.

PMID:
24850151
17.

Pathological implications of Cx43 down-regulation in human colon cancer.

Ismail R, Rashid R, Andrabi K, Parray FQ, Besina S, Shah MA, Ul Hussain M.

Asian Pac J Cancer Prev. 2014;15(7):2987-91.

18.

Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.

Yu M, Zhang C, Li L, Dong S, Zhang N, Tong X.

Oncol Rep. 2014 Jun;31(6):2751-8. doi: 10.3892/or.2014.3163. Epub 2014 Apr 29.

PMID:
24789679
19.

Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma.

Brockmeyer P, Jung K, Perske C, Schliephake H, Hemmerlein B.

Int J Oncol. 2014 Jul;45(1):273-81. doi: 10.3892/ijo.2014.2394. Epub 2014 Apr 23.

PMID:
24788723
20.

In search of genetic markers for nonsyndromic deafness in Africa: a study in Cameroonians and Black South Africans with the GJB6 and GJA1 candidate genes.

Bosch J, Lebeko K, Nziale JJ, Dandara C, Makubalo N, Wonkam A.

OMICS. 2014 Jul;18(7):481-5. doi: 10.1089/omi.2013.0166. Epub 2014 May 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk